Read + Share
Amedeo Smart
Independent Medical Education
Lin M, Luo T, Jin Y, Zhong X, et al. HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis. Cancer 2023 Nov 7. doi: 10.1002/cncr.35101.PMID: 37933913
Email
LinkedIn
Facebook
Twitter
Privacy Policy